Biomarker identification and patient stratification are essential for advancing precision medicine in schizophrenia, a condition with significant biological heterogeneity.
- 4 cites
Moving in BMJ.
Rebuilt
Biomarker identification and patient stratification are essential for advancing precision medicine in schizophrenia, a condition with significant biological heterogeneity.
Newest first · last 60 days
Journals this month
Topics moving, week to 23 Oct 2026